GC Biopharma Corp. (KRX:006280)
South Korea
· Delayed Price · Currency is KRW 139,200
-900 (-0.64%)
Last updated: Apr 29, 2026, 2:00 PM KST
GC Biopharma Revenue
In the year 2025, GC Biopharma had annual revenue of 1.99T KRW with 18.54% growth. GC Biopharma had revenue of 497.75B in the quarter ending December 31, 2025, with 12.91% growth.
Revenue
1,991.28B
Revenue Growth
+18.54%
P/S Ratio
0.80
Revenue / Employee
975.16M
Employees
2,042
Market Cap
1,598.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,991.28B | 311.39B | 18.54% |
| Dec 31, 2024 | 1,679.89B | 53.25B | 3.27% |
| Dec 31, 2023 | 1,626.64B | -84.67B | -4.95% |
| Dec 31, 2022 | 1,711.31B | 173.49B | 11.28% |
| Dec 31, 2021 | 1,537.83B | 33.71B | 2.24% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong Pharmaceutical | 1,570.89B |
| Chong Kun Dang Pharmaceutical | 1,692.40B |
| DongKook Pharmaceutical | 926.88B |
| Celltrion Pharm | 274.73B |
| Hanall Biopharma | 155.18B |
| Daewoong | 2,068.37B |
| Ildong Pharmaceutical | 566.93B |
| Boryung | 1,017.43B |
GC Biopharma News
- 6 months ago - MedGenome Makes a Majority Investment in Leading Gujarat-Based Diagnostics Chain Green Cross to Expand Genomics Offerings Across India - Business Upturn